Patent ID: 6159976
Filing Date: 2000-12-12
Classification: A61P,C07D

Abstract:
The polymorph of 3,4-dihydro-4-oxo-3-((5-(trifluoromethyl)-2-benzothiazolyl)methyl)-1-phtha lazineacetic acid monohydrate having the following characteristic x-ray powder diffraction pattern: 2-theta d/A 2-theta d/A 2-theta d/A  5.3 16.7 17.6 5.0 26.2 3.4 5.9 15.1 19.2 4.6 27.3 3.3 8.0 11.0 20.1 4.4 28.3 3.2 10.5 8.4 21.2 4.2 29.0 3.1 11.8 7.5 21.4 4.2 29.5 3.0 12.3 7.2 22.1 4.0 30.2 3.0 12.6 7.0 22.5 4.0 30.9 2.9 13.1 6.8 23.1 3.8 31.7 2.8 14.3 6.2 23.4 3.8 32.6 2.7 15.7 5.6 23.8 3.7 33.4 2.7 16.5 5.4 24.3 3.7 36.6 2.5 17.1 5.2 25.3 3.5